Stock 4114 SYNMOSA BIOPHARMA CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Synmosa Biopharma Corporation

Equities

4114

TW0004114004

End-of-day quote Taipei Exchange
Other stock markets
 23:00:00 22/05/2024 BST 		5-day change 1st Jan Change
39.5 TWD -1.13% Intraday chart for Synmosa Biopharma Corporation -0.38% +2.20%
03-29 Synmosa Biopharma Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
01-16 Synmosa Biopharma Corporation Announces Changes in Fifth Session of the Remuneration Committee CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Synmosa Biopharma Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Synmosa Biopharma Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Synmosa Biopharma Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Synmosa Biopharma Corporation Announces Cash Dividend, Payable on September 15, 2023
CI
Synmosa Biopharma Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Synmosa Biopharma Corporation Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Synmosa Biopharma Corporation Approves Dividend for the Year Ended December 31, 2022
CI
Synmosa Biopharma Corporation Provides Earnings Guidance for the Year 2022
CI
Synmosa Biopharma Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Synmosa Biopharma Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
Synmosa Biopharma Corporation Announces Cash Dividends, Payable on August 15, 2022
CI
Tranche Update on Synmosa Biopharma Corporation's Equity Buyback Plan announced on March 29, 2022.
CI
Synmosa Biopharma Corporation's Equity Buyback announced on May 29, 2022, has closed with 4,000,000 shares, representing 1.35% for TWD 108.97 million.
CI
Synmosa Biopharma Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Synmosa Biopharma Corporation Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Synmosa Biopharma Corporation announces an Equity Buyback for 4,000,000 shares, for TWD 1,177.47 million.
CI
Synmosa Biopharma Corporation authorizes a Buyback Plan.
CI
Synmosa Biopharma Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
Synmosa Biopharma Corporation Announces Cash Dividend for 2020, Payable on October 28, 2021
CI
Synmosa Biopharma Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4114 Stock
  4. News Synmosa Biopharma Corporation
  5. Highlights